And the risk score is much higher in cluster1, ER-, PR-, HER2+, TNBC, and advanced Grade patients, which indicates that the increased risk score also predicts a malignant breast cancer molecular phenotype. This evidence concerns the gene ESR1 and breast carcinoma.